Department of Urology, Fertility Center, CHA Gangnam Medical Center, CHA University, Seoul, Korea.
Department of Urology, CHA Fertility Center Seoul Station, CHA University, Seoul, Korea.
Investig Clin Urol. 2024 Jan;65(1):77-83. doi: 10.4111/icu.20230141.
Infertility affects 10% to 15% of couples, and male factor accounts for 50% of the cases. The relevant male genetic factors, which account for at least 15% of male infertility, include Y-chromosome microdeletions. We investigated clinical data and patterns of Y-chromosome microdeletions in Korean infertile men.
A total of 919 infertile men whose sperm concentration was ≤5 million/mL in two consecutive analyses were investigated for Y-chromosome microdeletion. Among them, 130 infertile men (14.1%) demonstrated Y-chromosome microdeletions. Medical records were retrospectively reviewed.
In 130 men with Y-chromosome microdeletions, 90 (69.2%) had azoospermia and 40 (30.8%) had severe oligozoospermia. The most frequent microdeletions were in the azoospermia factor (AZF) c region (77/130, 59.2%), followed by the AZFb+c (30/130, 23.1%), AZFa (8/130, 6.2%), AZFb (7/130, 5.4%), AZFa+b+c (7/130, 5.4%), and AZFa+c (1/130, 0.7%) regions. In men with oligozoospermia, 37 (92.5%) had AZFc microdeletion. Chromosomal abnormalities were detected in 30 patients (23.1%). Higher follicle-stimulating hormone level (23.2±13.5 IU/L vs. 15.1±9.0 IU/L, p<0.001), higher luteinizing hormone level (9.7±4.6 IU/L vs. 6.0±2.2 IU/L, p<0.001), and lower testis volume (10.6±4.8 mL vs. 13.3±3.8 mL, p<0.001) were observed in azoospermia patients compared to severe oligozoospermia patients.
Y-chromosome microdeletion is a common genetic cause of male infertility. Therefore, Y-chromosome microdeletion test is recommended for the accurate diagnosis of men with azoospermia or severe oligozoospermia. Appropriate genetic counseling is mandatory before the use of assisted reproduction technique in men with Y-chromosome microdeletion.
不孕不育影响了 10%至 15%的夫妇,其中 50%的病例与男性因素有关。相关的男性遗传因素至少占男性不育的 15%,包括 Y 染色体微缺失。我们调查了韩国不育男性的临床数据和 Y 染色体微缺失模式。
共对 919 名连续两次精液分析精子浓度≤500 万/ml 的不育男性进行了 Y 染色体微缺失检测。其中 130 名男性(14.1%)有 Y 染色体微缺失。回顾性查阅病历。
在 130 名 Y 染色体微缺失的男性中,90 名(69.2%)为无精子症,40 名(30.8%)为严重少精子症。最常见的微缺失发生在无精子因子(AZF)c 区(77/130,59.2%),其次是 AZFb+c 区(30/130,23.1%)、AZFa 区(8/130,6.2%)、AZFb 区(7/130,5.4%)、AZFa+b+c 区(7/130,5.4%)和 AZFa+c 区(1/130,0.7%)。在少精子症患者中,37 名(92.5%)有 AZFc 微缺失。30 名患者(23.1%)检测到染色体异常。无精子症患者的卵泡刺激素水平较高(23.2±13.5 IU/L 比 15.1±9.0 IU/L,p<0.001),黄体生成素水平较高(9.7±4.6 IU/L 比 6.0±2.2 IU/L,p<0.001),睾丸体积较小(10.6±4.8 mL 比 13.3±3.8 mL,p<0.001)。
Y 染色体微缺失是男性不育的常见遗传原因。因此,建议对无精子症或严重少精子症患者进行 Y 染色体微缺失检测,以做出准确诊断。对于 Y 染色体微缺失的男性,在使用辅助生殖技术之前,必须进行适当的遗传咨询。